Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Clinical trial NCT00920816 · COMPLETED

Trial details

NCT number: NCT00920816
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Kidney Neoplasms

Start date: 2009-08-25
Primary completion: 2012-07-27
Enrollment: 492

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.